""
UC Davis Medicine Logo
The institution's principal publication for alumni, friends and physicians.
""
Horizontal boundary
""
""
"" "" ""
  N E W S  
"" "" ""
"" Vascular center formed ""
""

""
"" New NIH-funded stem cell research center ""
""

""
"" Biophotonics headquarters dedicated ""
""

""
  More good news for breastfeeding  
""

""
  New Emergency Medicine chair  
""

""
  New Urology chair  
""

""
  NCI designation renewed  
     
  Hiking minority participation in cancer clinical trials  
     
  New regimen offers longer cancer survival rates  
     
  Improving women's heart health  
     
  Better ways to control cancer pain  
     
  Study explores health of immigrant families  
     
  NIH grant helps new clinical researchers  
     
  Howard Hughes' grant for basic science  
     
  Tobacco tied to high cancer death burden in African-American men  
     
  Genetic switch boosts radiation effectiveness  
     
  1% of retailers sell 40% of guns used in California crime  
     
  Possible inflammatory-disease treatments  
     
  Early clues to ovarian cancer  
     
  Healthy success for non-dieters  
     
  New student affairs assistant dean  
     
  UC Davis develops drug that may block breast cancer  
     
  Researchers report new drug-delivery approach  
Vertical Seperator Line
""
""
NEWS
""
""
"" ""
"" ""
 
""

Early clues to ovarian cancer

Ovarian cancer, referred to as a silent killer, makes itself apparent only at its late stages when prognosis is poor. But according to UC Davis researchers, four in 10 women with ovarian cancer have symptoms that they tell their doctors about at least four months — and as long as one year — before they are diagnosed. Published in Cancer, a peer-reviewed journal of the American Cancer Society, the study finds that patients with ovarian cancer were more likely than women in the other two groups to have seen their physicians for four symptoms: abdominal pain, abdominal swelling, gastrointestinal symptoms and pelvic pain. Overall, about 40 percent of women with ovarian cancer had physician claims indicating one or more visits for these symptoms four months or more before the cancer was diagnosed.

""
"" ""
 
"" ""
"" ""
Vertical Seperator Line
"" "" ""
     
"" "" Vertical Seperator Line "" "" "" ""
"" "" Vertical Seperator Line
""
""

UC DAVIS SCHOOL OF MEDICINE
PUBLIC AFFAIRS
4900 Broadway, Suite #1200
Sacramento, CA 95820

ucdavismedicine@ucdmc.ucdavis.edu

© 2006 UC Regents. All Rights Reserved.

"" "" ""